Phio Pharmaceuticals

PHIO

Capitalización de mercado USD 9.7 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Broadfin Capital New York	USD 1.36 M	-USD 176 k	-1	-11%
2	2 Renaissance Technologies New York	USD 257 k	+USD 176 k	+1	+100%
3	3 Vanguard Group Malvern, Pennsylvania	USD 247 k	+USD 176 k	+1	+100%
4	4 Geode Capital Management Boston, Massachusetts	USD 71 k	–	–	–
5	5 Susquehanna International Group Bala Cynwyd, Pennsylvania	USD 56 k	–	–	–
6	6 Virtu KCG Holdings New York	USD 43 k	–	–	–
7	7 BlackRock Institutional Trust San Francisco, California	USD 29 k	–	–	–
8	8 Citadel Advisors Miami, Florida	USD 25 k	–	–	–
9	9 UBS Group Zurich, Switzerland	USD 6 k	–	–	–
10	10 Bank of America Charlotte, North Carolina	USD 5 k	–	–	–
11	11 Goldman Sachs New York	USD 5 k	–	–	–
12	12 BlackRock Fund Advisors San Francisco, California	USD 4 k	–	–	–
13	13 People's United Financial Bridgeport, Connecticut	USD 4 k	–	–	–
14	14 Two Sigma Securities New York	USD 4 k	–	–	–
15	15 Northern Trust Chicago, Illinois	USD 3 k	–	–	–
16	16 Anson Funds Management Dallas, Texas	–	-USD 328 k	-1	Cerradas